source
- Amgen initiates three late-stage trials of obesity shot MariTide, including a switch-patient studyAmgen announced the start of three new Phase 3 trials for its long-acting obesity injection, MariTide. One of the studies will enroll participants who are transitioning away from the GLP-1 therapi…
- Moderna reports Q1 revenue surge driven by international COVID vaccine sales despite larger net lossModerna posted first‑quarter revenue of $389 million, more than triple the same period a year earlier, primarily from overseas COVID‑19 vaccine sales. The company recorded a net loss of $1.3 billi…